Forecasting the Future: Infectious Disease Diagnostics Market Set to Reach $33.1 Billion by 2027 | Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland)

Infectious Disease Diagnostics Market Research, 2027

The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR. Growth in the infectious disease diagnostics industry is mainly driven by factors such as the rising prevalence of infectious diseases and the rising funding for R&D in infectious disease diagnostics.

To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

The infectious disease diagnostics market refers to the industry involved in the development, manufacturing, and distribution of diagnostic tests and tools for detecting infectious diseases in humans and animals. Infectious disease diagnostics are critical for the early identification and management of infectious diseases, as they enable healthcare professionals to diagnose and treat infections promptly, prevent the spread of diseases, and track disease outbreaks.

Key components of the infectious disease diagnostics market include:

Diagnostic Tests: These are laboratory or point-of-care tests used to detect the presence of infectious agents, such as bacteria, viruses, fungi, and parasites, in patient samples like blood, urine, or swabs.

Instruments and Equipment: Laboratories and healthcare facilities use specialized instruments and equipment for processing and analyzing diagnostic samples.

Reagents and Consumables: Reagents, test kits, and other consumables are essential for performing diagnostic tests accurately.

Software and Information Systems: Information management systems and software help healthcare professionals track and manage infectious disease data, which is crucial for monitoring and responding to outbreaks.

Services: Companies in the infectious disease diagnostics market often provide services such as test validation, training, technical support, and maintenance to healthcare facilities.

Point-of-Care Testing (POCT): POCT refers to diagnostic tests performed near the patient, often at the bedside or in clinics, providing rapid results.

Telemedicine and Remote Monitoring: In recent years, telemedicine and remote monitoring have gained importance, allowing patients to consult with healthcare providers and share diagnostic data remotely, especially during the COVID-19 pandemic.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Key Market Players:

The major players in this market are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Siemens Healthineers AG (Germany), Danaher Corporation (US), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics Holdings plc (US), Quidel Corporation (US), Meridian Bioscience (US), Genetic Signatures Ltd. (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems (US), Seegene, Inc. (South Korea), Co-Diagnostics (US), ELITechGroup (France), Epitope Diagnostics (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International (US), Vela Diagnostics (Singapore) and Uniogen Oy (Finland).

Abbott Laboratories accounted for the largest share of the infectious disease diagnostics market. Abbott Laboratories is a leading player in the infectious disease diagnostics market. The launch of the ID NOW POC testing system by the company is expected to support the growth of its infectious disease diagnostics segment.

F. Hoffmann-La Roche Ltd. accounted for the second largest share of the infectious disease diagnostics market in 2021. Under its flagship brand- cobas- the company offers a wide variety instruments and reagents that are widely used by end users across the globe.

Thermo Fisher Scientific accounted for the third largest share of the infectious disease diagnostics market. It is one of the key players operating in the infectious disease diagnostics market. The company's leading position in this market can be attributed to its strong sales and distribution network, enabling it to effectively market its products in various countries.

North America is the largest regional market for infectious disease diagnostics market

North America accounted for the largest share of the market. The large share of this region can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.

Contact us for Special Discount and Pricing @: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=116764589&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

This release was published on openPR.